ICFSR

The design and rationale of the ENRGISE study

This symposium was presented at ICFSR 2018 (Miami Beach, USA, 1-3 March 2018). Enabling Reduction of low-Grade Inflammation in Seniors -Pilot Study. The ENRGISE Pilot Studywill provide preliminary data to design a definitive clinical trial to assess whether the reduction… Continue Reading →

ICFSR

Frailty: what’s been done and what needs doing

Frailty is the “raison d’être” for Geriatric, see Linda Fried’s presentation during the International Conference on Frailty & Sarcopenia Research (ICFSR2018) (Miami, USA, March 1-3, 2018)

ICFSR, Research & Science

Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force

Establishment of an ICD-10-CM code for sarcopenia was an important step towards reaching international consensus on the need for a nosological framework of age-related skeletal muscle decline. The International Conference on Frailty and Sarcopenia Research Task Force met in April… Continue Reading →

The design and rationale of the ENRGISE study

Frailty: what’s been done and what needs doing

Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force

Recent Posts

Slider